93 results
Guidelines for Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip
Perioperative Management ... Antirheumatic Medication ... MithuRheum #rheumatology ... #medications #hold ... #autoimmune #pharmacology
NSAIDs and GI versus CV risk

Follow www.instagram.com/rxnotes for more!

#pharmacology #comparison #cardiology #gi #nsaids #pain #medications #management
and GI versus CV risk ... #pharmacology #comparison ... #nsaids #pain #medications ... #management #riskfactors
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Each class of medications ... own benefits and risks ... the hypoglycemia risk ... #pharmacology #pharmacotherapy ... table #comparison #management
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
Infection Control Risk ... COVID-19 Specific Medications ... Respiratory Cardiac Hematologic ... NonIntensivist #diagnosis ... #management
Beta-Blockers in Cirrhosis
 • Pathophysiology
 • Indications:  Prevention of decompensation, Prevention of first variceal bleeding,
Pathophysiology • Indications ... BetaBlockers #Cirrhosis #hepatology ... #management #pharmacology ... #indications #dosing
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
treatment #hcv #medications ... infectiousdisease #hepatology ... HepC #HepatitisC #Management ... #Pharmacology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #management #algorithm ... #pharmacology # ... treatment #medications ... decisionaid #cardiology #hematology
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary
myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
and Management ... and risk-stratification ... • Risks: infection ... #Management #treatment ... #hematology #oncology
PocketPEM - BRUE - Brief Resolved Unexplained Events #Diagnosis #Management #Peds #EM #BRUE #Risk #PocketCard #PocketPEM
Unexplained Events #Diagnosis ... #Management #Peds ... #EM #BRUE #Risk
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Tranexamic Acid - Indications ... and Pharmacology ... fatigue; Increases risk ... #Pharmacology # ... hematology